Bss (Balanced Salt Solution)

Package · 500 mL in 1 BOTTLE

Active ingredients · Calcium Chloride, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Citrate

Balanced Salt Solution · Solution · .48 mg/mL / .3 mg/mL · Ophthalmic

NDC

00065-0795-50

Route

Ophthalmic

Therapeutic class

Blood Coagulation Factor , Calcium [CS], Calculi Dissolution Agent , Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Phosphate Binder , Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Marketing category

NDA